Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene (Q24304157)

positive regulation of transcription, DNA-templated

GOA release 2020-03-11

1 reference

Wilms tumor protein homolog

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

1 reference

1 reference

Christof Dame

0 references

Karin M Kirschner

0 references

Katharina V Bartz

0 references

Thomas Wallach

0 references

Christiane S Hussels

0 references

Holger Scholz

An inhibitor domain in Sp3 regulates its glutamine-rich activation domains.

0 references

language of work or name

English

0 references

publication date

1 June 2006

0 references

published in

Blood

0 references

volume

107

0 references

issue

0 references

page(s)

4282-90

0 references

cites work

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Wilms tumor and the WT1 gene

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Non-erythroid functions of erythropoietin

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Beneficial and ominous aspects of the pleiotropic action of erythropoietin

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Erythropoietin production by the liver in fetal-neonatal life

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

WT-1 is required for early kidney development

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

A cross-talk between hypoxia and TGF-beta orchestrates erythropoietin gene regulation through SP1 and Smads

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Wt1 is not essential for hematopoiesis in the mouse

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Erythropoietin is neuroprotective in models of HIV sensory neuropathy

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Wt1 functions in the development of germ cells in addition to somatic cell lineages of the testis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Wilms' tumor suppressor (WT1) is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

The Wilms' tumor suppressor Wt1 encodes a transcriptional activator of the class IV POU-domain factor Pou4f2 (Brn-3b)

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

YAC transgenic analysis reveals Wilms' tumour 1 gene activity in the proliferating coelomic epithelium, developing diaphragm and limb.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

The Wilms tumor suppressor gene wt1 is required for development of the spleen.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

The candidate Wilms' tumour gene is involved in genitourinary development

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Forced expression of the Wilms tumor 1 (WT1) gene inhibits proliferation of human hematopoietic CD34(+) progenitor cells

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Cloning and expression of the human erythropoietin gene

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

The regulated expression of erythropoietin by two human hepatoma cell lines

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Truncated WT1 mutants alter the subnuclear localization of the wild-type protein

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Hepatic erythropoietin gene regulation by GATA-4.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Complexity of translationally controlled transcription factor Sp3 isoform expression.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

The Wilms' tumor gene Wt1 is required for normal development of the retina

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

The role of the near upstream sequence in hypoxia-induced expression of the erythropoietin gene

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Oxygen‐regulated expression of the Wilms’ tumor suppressorWt1involves hypoxia‐inducible factor‐1 (HIF‐1)

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Expression of the Wilms' tumor gene WT1 in the murine urogenital system

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant.

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Erythropoietin messenger RNA levels in developing mice and transfer of 125I-erythropoietin by the placenta

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Role of the WT1 tumor suppressor in murine hematopoiesis

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Erythropoietin expression in primary rat Sertoli and peritubular myoid cells

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021

Evidence for specific binding and stimulatory effects of recombinant human erythropoietin on isolated adult rat Leydig cells

1 reference

https://api.crossref.org/works/10.1182%2FBLOOD-2005-07-2889

7 January 2021